bf/NASDAQ:GOVX_icon.jpeg

NASDAQ:GOVX

GeoVax Labs, Inc.

  • Stock

USD

Last Close

2.73

18/09 20:00

Market Cap

8.09M

Beta: 3.00

Volume Today

327.81K

Avg: 341.24K

PE Ratio

−2.88

PFCF: −0.23

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    www.geovax.com
  • ipo date

    Sep 25, 2020

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, ...Show More

peer of

Earnings

Earnings per Share (Estimate*)

-800000-600000-400000-2000002015-03-202017-03-242019-03-272021-03-232023-03-23

Revenue (Estimate*)

200K400K600K800K2015-03-202017-03-242019-03-272021-03-232023-03-23

*Estimate based on analyst consensus